Growing community of inventors

Guilford, CT, United States of America

Stephan Ortiz

Average Co-Inventor Count = 5.78

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 5

Stephan OrtizXiang Gao (2 patents)Stephan OrtizRajendra Pradhan (2 patents)Stephan OrtizBruce Mason (2 patents)Stephan OrtizLori Payton (2 patents)Stephan OrtizLeena Philominathan (2 patents)Stephan OrtizEric Routhier (2 patents)Stephan OrtizJillian Gentile (2 patents)Stephan OrtizEric Routhier (1 patent)Stephan OrtizAndrew Evan Denker (1 patent)Stephan OrtizScott T Rottinghaus (1 patent)Stephan OrtizMarc Vallee (1 patent)Stephan OrtizEugene Scott Swenson (1 patent)Stephan OrtizMasayo Ogawa (1 patent)Stephan OrtizChristian Mix (1 patent)Stephan OrtizStephan Ortiz (4 patents)Xiang GaoXiang Gao (5 patents)Rajendra PradhanRajendra Pradhan (5 patents)Bruce MasonBruce Mason (3 patents)Lori PaytonLori Payton (3 patents)Leena PhilominathanLeena Philominathan (2 patents)Eric RouthierEric Routhier (2 patents)Jillian GentileJillian Gentile (2 patents)Eric RouthierEric Routhier (4 patents)Andrew Evan DenkerAndrew Evan Denker (7 patents)Scott T RottinghausScott T Rottinghaus (2 patents)Marc ValleeMarc Vallee (2 patents)Eugene Scott SwensonEugene Scott Swenson (1 patent)Masayo OgawaMasayo Ogawa (1 patent)Christian MixChristian Mix (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Alexion Pharmaceuticals, Inc. (4 from 196 patents)


4 patents:

1. 12460012 - Dosage and administration of anti-C5 antibodies for treatment of atypical hemolytic uremic syndrome (aHUS) in pediatric patients

2. 12404320 - Dosage and administration of anti-C5 antibodies for treatment of paroxysmal nocturnal hemoglobinuria (PNH) in pediatric patients

3. 12012448 - High concentration anti-C5 antibody formulations

4. 11365241 - High concentration anti-C5 antibody formulations

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/11/2026
Loading…